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Objectives: There is evidence suggesting that secondhand smoke (SHS) exposure is
causally linked to adverse respiratory effects. We examined the relations between the
exposure to SHS and radiological signs in chest high-resolution computed tomography
(HRCT).
Methods: Asbestos-exposed workers (n ¼ 633) were imaged with HRCT, primarily to
investigate potential occupational lung disease. After excluding current smokers, the
study population included 361 ex- and 141 never-smokers. They answered a questionnaire
on occupational exposures, smoking habits and SHS exposure. HRCT images were assessed
for emphysema, ground-glass, irregular/linear and rounded opacities, honeycombing and
several other signs. Regression analyses were adjusted for asbestos exposure, ex-smoking,
age, body mass index and potential reader effect.
Results: Due to missing data the multivariate analyses were restricted to 310 participants
aged 47.5–87.0 years. Their lifetime SHS exposure ranged between 0 and 193.5 pack-years
(mean 23.5), and exposure in the past 12 months 0–30 packs (0.43). Total (B ¼ 0.005, 95%
confidence intervals (95% CI) 0.002–0.008, p ¼ 0.000) and workplace (B ¼ 0.006, 95% CI
0.003–0.009, p ¼ 0.001) cumulative SHS exposures were significantly related to ground-
glass opacities. Total SHS exposure in the last 12 months (B ¼ 0.027, 95% CI 0.000–0.054,
p ¼ 0.048) and workplace exposure (B ¼ 0.027, 95% CI 0.000–0.054, p ¼ 0.048) were alsoElsevier Ltd. All rights reserved.
terstitial pneumonia; GGO, ground-glass opacity; HRCT, high-resolution computed tomography; HU,
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The effects of secondhand smoke exposure on HRCT findings 659significantly related to ground-glass opacities. Positive effects of SHS were also detected
on irregular/linear opacities.
Conclusions: SHS exposure in the last 12 months and over lifetime significantly increases
ground-glass opacity in HRCT, suggesting an early or subclinical desquamative interstitial
pneumonia/respiratory bronchiolitis. This study further supports that SHS has adverse
effects on the lungs that can be detected by X-ray methods.
& 2008 Elsevier Ltd. All rights reserved.Introduction
Since the 1980s, evidence has accumulated on the adverse
health effects of secondhand smoke (SHS), also called
passive smoking, exposure to environmental tobacco smoke
and involuntary smoking. The adverse respiratory effects of
SHS include lung cancer,1 chronic respiratory symptoms,2–4
lung function impairment,5–7 chronic obstructive pulmonary
disease8 and asthma.9 However, there is little data on
potential effects of SHS exposure on diseases of the lung
parenchyma.
High-resolution computed tomography (HRCT) has been
shown to detect pathological lung changes in symptom-free
smokers with normal chest radiographies and normal lung
function.10 Even limited smoking (o10 pack-years) has been
found to induce detectable HRCTabnormalities.11 This raises
the question whether SHS exposure could induce such
changes. As pulmonary function tests often fail to identify
the early stages of smoke-induced diseases, HRCT could
prove to be a more sensitive clinical test. According to our
knowledge, the relations between SHS exposure and HRCT
signs have not been studied before. This may be partly due
to the ethical problems in imaging healthy individuals with
ionizing radiation, unless there is a specific clinical indica-
tion to carry out such investigation.
We studied the effects of SHS exposure on several HRCT
signs among asbestos-exposed workers, who were examined
primarily for potential occupational lung diseases.12Methods
Study design
The study was a cross-sectional multicentre study of 633
asbestos-exposed workers in three cities (Helsinki, Tampere
and Turku) in Finland. All participants underwent an imaging
with HRCT, and answered a questionnaire in 2003–2004.12Study population
The study population included asbestos-exposed workers
who visited the clinics of occupational medicine for a
clinical follow-up or had participated in a previous asbestos
screening programme at the Finnish Institute of Occupa-
tional Health in 1990–1992.13 Current smokers were ex-
cluded from the present analyses focusing on SHS exposure,
so the final study population included 141 never- and 361 ex-
smokers, altogether 502 non-smokers. Of them 310 (all men,
aged 47.5–87.0 years, mean age 65) completed all questionsin the questionnaire, including a comprehensive matrix on
SHS exposure.
All participants gave their written informed consent and
the ethics committee approvals of the study protocol were
obtained at all the participating centres.
Questionnaire
The self-administered questionnaire was modified from the
Finnish Environment and Asthma Study questionnaire.9 It
included questions on demographic characteristics, respira-
tory symptoms and diseases, smoking status and an exposure
matrix on SHS exposure. Questions on other occupational
exposures with focus on asbestos exposure were added to
this questionnaire.
Imaging
We used three different scanners: two single-slice scanners,
Siemens Somatom Balance (Siemens Medical, Erlangen,
Germany) in Helsinki, Siemens Somatom Plus 4 (Siemens
Medical) in Tampere, and one multislice scanner, GE Light-
speed 16 Advantage (GE Healthcare, Milwaukee, WI, USA) in
Turku. HRCT images were obtained during a full inspiration
in a prone position. The slice thickness was 1–1.25mm. The
slices were taken at 3-cm intervals from the lung apex to
the costophrenic angle. The imaging parameters were
130–140 kV and 100–111mA. The images were printed as
hard copies at window settings appropriate for viewing the
lung parenchyma. In Tampere and Turku the window width
was 1500Hounsfield Unit (HU) and window level 600HU. In
Helsinki the interpreters used two settings in the same
session: 1200/700, and 2000/400HU. The difference
between centres was due to the fact that the observer
groups were used to these different settings in their clinical
practice.
Image analysis
The HRCT images were assessed by two radiologists in
consensus (TVe and TA in Helsinki, and RJ and TVi in Tampere
and Turku). The assessment was performed blinded to
smoking habits and other exposure data of the participants.
For the assessment both lungs were divided into three
zones: upper, middle and lower. Each of the six zones was
scored for each HRCT sign on a scale of 0–3: 0—no definitive
abnormality, 1—mild, 2—moderate and 3—severe abnorm-
ality. These were then summed up for both lungs. Final score
0 indicated a normal finding and the maximal score was the
sum of scores (0–3) for each lung at three levels. The
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recommendations,14 were evaluated: (a) well-defined
rounded opacities,o10mm in diameter (1 ¼ small opacities
definitely present but few in number, 2 ¼ numerous small
opacities and 3 ¼ small opacities very numerous, normal
anatomical lung structures poorly visible, sum grade of six
zones: 0–18); (b) irregular and/or linear opacities
(1 ¼ abnormalities definitely present but few in number,
2 ¼ numerous abnormalities and 3 ¼ abnormalities very
numerous, normal anatomical lung structures poorly visible,
sum grades 0–18); (c) ground-glass opacities (GGOs)
(1 ¼ focal, 2 ¼ patchy and 3 ¼ diffuse, sum grades 0–18);
(d) honeycombing (1 ¼ up to 10mm, 2 ¼410–30mm
extent in the subpleural parenchyma and 3 ¼430mm up
to whole area, sum grades 0–18); and (e) emphysema
(1 ¼ up to 15%, 2 ¼ between 15% and 30% and 3 ¼430% of
the area of one zone, sum grades 0–18). In addition, the
presence of several other radiological signs (yes/no) were
noted and those with a relatively frequent occurrence
(nX15) were included as outcomes in statistical analyses:
bronchiectasis, bronchial wall thickening, suspicion of lung
cancer, calcified granuloma, dependent opacity, parenchy-
mal band, rounded atelectasis, subpleural curvilinear line
and tuberculosis. The scoring was conducted according to a
published international system with standardized instruc-
tions and reference images.15
Exposure assessment
The information on SHS exposure was obtained with a
questionnaire. The SHS exposure was self-reported, includ-
ing both the past 12 months’ exposure at work and at home
and a lifetime exposure in10 age periods: 0–1, 2–6, 7–15,
16–20, 21–30,y,71–80 years, with separate reporting of
exposure at home and at work. The number of cigarettes the
subject was exposed to daily and the duration of exposure
(in years) were reported for each age period. Cumulative
exposure was calculated as SHS pack-years (one pack ¼ 20
cigarettes). For statistical analyses the age periods were
summed to form a cumulative lifetime exposure index for
0–80 years.
Confounders
Current smokers were excluded from the study population,
so the population included only never-smokers and ex-
smokers. A never-smoker was a person who had never
smoked regularly, and an ex-smoker had stopped smoking at
least 12 months ago. The amount of smoking was inquired
and the pack-years estimated for ex-smokers. Smoking
status was grouped into ex- and never smoking, and
multivariate analyses adjusted for both smoking status and
pack-years of ex-smokers. The duration and amount of the
asbestos exposure were assessed, and asbestos-exposure
index was calculated for adjustment in multivariate
models.16
Statistical methods
The mean scores of the radiological signs formed the
outcomes of interest. The exposures of interest were theSHS exposure in the past 12 months and the total lifetime
SHS exposure index as continuous variables. Home and work
exposures were analysed separately and combined. Multiple
linear regression was used to study the relations between
SHS exposure and the radiological signs, adjusting for
age, asbestos-exposure index, smoking status (ex-smoker
vs. never smoker), potential image interpreter effect
(1 ¼ RJ/TVi, 0 ¼ TA/TVe), body mass index (weight
[kg]/height [m]2)17 and pack-years of active smoking for
ex-smokers. Results are given as regression coefficients and
95% confidence intervals (95% CI). Due to the concern that
collinearity could distort regression estimates, the variance
inflation factors (VIF) were determined for each model.
Multiple logistic regression with the same covariates was
used for binary radiological signs.
Some additional statistical procedures were also used to
further clarify the relations:1. Because the distributions of the radiological scores were
skewed to the right and transformation did not correct
this, ordinal regression was used as a confirmatory
analysis method.2. The analyses were carried out in a subgroup of never-
smokers only.
Results
The final statistical analyses were conducted in 310
participants (91 never-smokers and 219 ex-smokers). The
characteristics of the study population are presented in
Table 1.
The comparison between respondents (who had com-
pleted all SHS questions) and non-respondents (with missing
information) showed no major differences, although the
non-responders were slightly older.
The lifetime SHS exposure ranged between 0 and 193.5,
with the mean of 23.5 pack-years. The SHS exposure in the
past 12 months ranged between 0 and 30 packs, with the
mean 0.43 packs.
In multivariate regression analysis, both total SHS
exposure in the past 12 months (B ¼ 0.027, 95% CI
0.000–0.054, p ¼ 0.048) and total lifetime SHS exposures
(B ¼ 0.005, 95% CI 0.002–0.008, p ¼ 0.000) were signifi-
cantly related to increasing GGO (Figure 1) score (Tables 2
and 3).
There was also a borderline significant effect of lifetime
SHS exposure on irregular and/or linear opacities
(B ¼ 0.006, 95% CI 0.000–0.013, p ¼ 0.059). The relations
between the total SHS exposure and other HRCT signs were
not statistically significant.
When SHS at work and at home were studied separately,
the relation with GGOs was observed with both workplace
SHS exposure in the past 12 months (B ¼ 0.027, 95% CI
0.000–0.054, p ¼ 0.048) and cumulative lifetime workplace
exposure (B ¼ 0.006, 95% CI 0.003–0.009, p ¼ 0.001).
Adjustment for the other type of SHS exposure in the
models did not influence much the effect estimates,
although after that the effects of recent exposure were no
more statistically significant. Both home SHS exposure in the
past 12 months and lifetime home SHS exposure were also
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Table 1 Characteristics of the study population including ex- and never-smokers.
Characteristics Responders Non-responders All p-Value
N Mean/SD
(range)
N Mean/SD
(range)
N Mean/SD
(range)
Age, years 310 65.0/6.6
(47.5–87.0)
192 66.0/7.0
(45.0–85.0)
502 65.0/6.8
(45.0–87.0)
0.034
Pack-years 303 12.8/16.0
(0–129.0)
177 14.2/14.7
(0–70.0)
480 13.3/15.5
(0–129.0)
0.354
Cumulative pack-years
of SHS exposure
310 23.5/25.2
(0–193.5)
310 23.5/25.2
(0–193.5)
Body mass index (kg/m2) 298 28.2/4.2
(20.1–47.5)
182 28.8/3.9
(19.7–43.6)
480 28.4/4.1
(19.7–47.5)
0.164
Asbestos-exposure index 310 79.1/48.8
(8.0–286.0)
191 71.3/44.4
(4.0–252.0)
501 76.1/47.3
(4.0–286.0)
0.069
Responders answered the secondhand smoke (SHS) exposure questions (N ¼ 310).
t-Test for differences between responders and non-responders.
Figure 1 Ground-glass opacity in HRCT. Patchy areas indicate
GGO (arrows).
The effects of secondhand smoke exposure on HRCT findings 661related to increased GGOs, but these effects did not reach
statistical significance. Home SHS exposure in the past 12
months was also related to increased irregular and/or linear
opacities (B ¼ 1.873, 95% 0.512–3.233, p ¼ 0.007) and
honeycombing (B ¼ 1.100, 95% CI 0.675–1.524, p ¼ 0.000).
When the analyses were conducted in the subgroup of
never-smokers, no significant associations were detected,
probably due to the small sample size. Ordinal regression
models confirmed the results by providing practically similar
findings in all analyses. No collinearity problem was found
when VIFs were determined.Discussion
The main finding in our study of 310 asbestos-exposed
workers investigated with HRCT was a significant effect of
both SHS exposure in the past 12 months and lifetime
cumulative SHS exposure on GGOs. In addition, irregular/
linear opacities showed a positive relation with SHS
exposure. To our knowledge, this is the first studyinvestigating the effects of SHS exposure on chest HRCT
signs.
The workplace exposure was significantly related to GGO
both in the past 12 months and over lifetime. The effects on
GGO related to home exposures were of similar magnitude,
but did not reach statistical significance probably due to the
small number of participants that reported exposure at
home.
GGO in HRCT images is defined as ‘hazy increased
attenuation of lung, but with preservation of bronchial and
vascular margins’.14,18 It is a non-specific finding and
correlates histologically with partial filling of air spaces,
inflammatory or fibrotic interstitial thickening, partial
collapse of alveoli, or increased capillary blood volume.14,18
Numerous disease processes can result in GGO as the sole or
dominant finding in CT scans of the lung, including extrinsic
allergic alveolitis, alveolar proteinosis, pulmonary oedema,
and interstitial pneumonias.18 In chronic diffuse lung
diseases GGO has been found to be a reliable indicator of
inflammation in the absence of signs of fibrosis, a good
prognostic factor, and in active diseases it is usually
reversible.19–21
Remy-Jardin et al.10 did not detect GGO in CT scans of 51
non-smokers. A study of Vikgren et al.22 found GGO to be a
part of smoking-induced disease. They showed that the
progression in the extent of GGO was seen among smokers in
a 6-year interval, but that the occurrence of GGO was higher
among ex-smokers than among never-smokers. Septal lines
were found in both never- and current smokers.
Respiratory bronchiolitis (RB) is a common incidental
histopathologic finding in otherwise healthy cigarette
smokers.23 In rare cases the condition presents as a form
of interstitial lung disease with significant pulmonary
symptoms, and abnormal pulmonary function, when the
entity is called respiratory bronchiolitis-associated inter-
stitial lung disease (RB-ILD).24–26 Cigarette smoking has also
been related to rare interstitial lung disease, named
desquamative interstitial pneumonia (DIP).24,27,28 DIP is
considered to be a more extensive form of RB-ILD and it
seems likely that these entities represent different stages of
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Table 2 Effect of secondhand smoke (SHS) (smoking rate in packs) in the past 12 months on the scores of high-resolution
computed tomography (HRCT) signs.
HRCT sign SHS exposure
location
B 95% p-Value By 95% p-Value
Lower Upper Lower Upper
Well-defined rounded
opacities
Work 0.000 0.021 0.020 0.964 0.001 0.022 0.020 0.921
Home 0.065 0.482 0.352 0.760 0.065 0.483 0.353 0.760
Total 0.001 0.021 0.020 0.947 0.001 0.022 0.019 0.906
Irregular and/or
linear opacities
Work 0.024 0.081 0.032 0.399 0.029 0.087 0.028 0.315
Home 1.873 0.512 3.233 0.007 1.847 0.491 3.202 0.008
Total 0.025 0.082 0.032 0.389 0.030 0.087 0.028 0.308
Ground-glass opacity
grade
Work 0.027 0.000 0.054 0.048 0.020 0.007 0.047 0.151
Home 0.066 0.490 0.623 0.815 0.044 0.501 0.588 0.875
Total 0.027 0.000 0.054 0.048 0.020 0.007 0.047 0.148
Honeycombing grade Work 0.000 0.014 0.013 0.970 0.000 0.013 0.014 0.945
Home 1.100 0.675 1.524 0.000 1.093 0.669 1.517 0.000
Total 0.000 0.014 0.013 0.975 0.001 0.013 0.014 0.940
Emphysema grade Work 0.011 0.066 0.088 0.777 0.015 0.063 0.094 0.702
Home 0.645 2.482 1.192 0.490 0.636 2.477 1.204 0.497
Total 0.010 0.068 0.087 0.803 0.014 0.065 0.093 0.727
Adjusted for the following confounders: age, asbestos-exposure index, smoking status (ex-smoker vs. never smoker), potential
reader effect, body mass index, and pack-years of active smoking for ex-smokers.
yAdjusted for all confounders mentioned above and also for cumulative SHS exposure.
T. Vierikko et al.662the same disease.24,27 In these diseases HRCTcan sometimes
be normal. When abnormalities are detected, the signs that
may be seen include GGOs, linear and reticular opacities,
and small poorly defined nodules.24,25,27,29–31 There is also
considerable overlap in the radiologic and histopathologic
findings of these entities.24,26 SHS is composed of side
stream smoke (about 80%) and exhaled mainstream smoke
with similar carcinogenic, toxic and irritant chemicals as are
found in mainstream smoke. Our findings of the relation
between SHS exposure and GGO could be caused by the
same kind of pathological changes that are noted in active
smokers. GGO might represent a mild form of RB, RB-ILD or
DIP, and the linear/irregular opacities could indicate mild
fibrosis due to long-lasting exposure. We excluded current
smokers from our study population and controlled for ex-
smoking in the multivariate analyses to ensure that active
smoking could not explain our findings related to SHS
exposure.
A limitation of our study was the small number of never-
smokers. The histopathologic changes of RB can persist after
cessation of smoking, but they often resolve.32 RB was found
in all current smokers but only in 49% of ex-smokers. There is
evidence that areas of GGO in proven RB-ILD cases decrease
after smoking cessation.33 In all heavy smokers in the study
by Nakanishi et al. the scores for the GGO and centrilobular
nodules decreased significantly after smoking cessation,
while those for linear-reticular opacity and emphysema
were not changed. The smoking cessation had occurred15–52 months before the follow-up HRCT study. Also in a
longitudinal follow-up study of patients with smoker’s lung
GGO attenuation was reduced in those who had stopped
smoking.34 On follow-up HRCT of patients with RB-ILD and
DIP, areas of GGO showed resolution after smoking cessation
and treatment.35,36 The ex-smokers in the present study had
stopped smoking 1–52 years before the HRCT imaging (mean
25.0); so, based on the results from previous studies, it is
likely that the RB and GGO caused by previous active
smoking had reduced or disappeared by the time of our
study.
The harmful effects of SHS on HRCTsigns were found to be
dependent on the dose, the average score increasing by
0.005 for each pack-year of exposure. Most of the
participants of the present study were construction workers
working mainly outdoors, which may have diluted their SHS
exposure at work, and this, along with the limited sample
size, may have influenced our ability to detect any possible
association between SHS and emphysema or other radi-
ological signs.
A limitation of our study is that only 310 out of 502
participants (61.8%) completed all the questions on SHS
exposure. We compared the responders to those with
missing information and found that there were no major
differences in their background characteristics.
The exposure assessment was based on self-report, which
may have caused some misclassification. However, this was
the best assessment method available, as we hypothesized
ARTICLE IN PRESS
Table 3 Effect of lifetime cumulative secondhand smoke exposure (SHS) (pack-years) on the scores of high-resolution
computed tomography (HRCT) signs.
HRCT sign SHS exposure
location
B 95% p-Value By 95% p-Value
Lower Upper Lower Upper
Well-defined rounded
opacities
Work 0.002 0.005 0.000 0.105 0.000 0.002 0.002 0.746
Home 0.005 0.001 0.008 0.011 0.000 0.002 0.002 0.972
Total 0.000 0.002 0.002 0.942 0.000 0.002 0.002 0.754
Irregular and/or
linear opacities
Work 0.005 0.003 0.014 0.217 0.003 0.003 0.009 0.303
Home 0.011 0.001 0.023 0.082 0.006 0.001 0.012 0.074
Total 0.006 0.000 0.013 0.059 0.003 0.003 0.009 0.306
Ground-glass opacity
grade
Work 0.006 0.003 0.009 0.001 0.004 0.002 0.007 0.001
Home 0.005 0.000 0.010 0.059 0.005 0.002 0.007 0.000
Total 0.005 0.002 0.008 0.000 0.004 0.002 0.007 0.001
Honeycombing grade Work 0.001 0.001 0.004 0.375 0.000 0.002 0.001 0.528
Home 0.003 0.001 0.007 0.110 0.002 0.000 0.004 0.134
Total 0.002 0.000 0.004 0.124 0.000 0.002 0.001 0.521
Emphysema grade Work 0.002 0.013 0.009 0.724 0.002 0.010 0.005 0.536
Home 0.002 0.019 0.014 0.775 0.002 0.011 0.007 0.651
Total 0.002 0.011 0.007 0.669 0.002 0.010 0.005 0.535
Adjusted for the following confounders: age, asbestos-exposure index, smoking status (ex-smoker vs. never smoker), potential
reader effect, body mass index, and pack-years of active smoking for ex-smokers.
yAdjusted for all confounders mentioned above and also for SHS exposure in the past 12 months.
The effects of secondhand smoke exposure on HRCT findings 663that long-term exposure is of biological relevance in our
study.37 Currently there are no biomarkers for SHS exposure
that would measure long-term exposure. In a study of
Coultas et al.38 repeated self-reports of the duration (years)
of exposure to SHS were reliable, while the reports on the
amount of cigarettes smoked were somewhat less reliable.
Another study showed a good agreement between the
subjects’ own questionnaire reports on SHS exposure and
surrogate reports of most exposure measures.39 The ques-
tionnaire allows the exposure assessment on several periods
of life retrospectively when it is no longer possible to
monitor the exposure with other methods.
The studied participants were not a random population
sample and the results cannot be extrapolated directly to
the general population. In many countries it is not
considered ethically correct to expose healthy volunteers
with X-rays to study CT signs due to mild exposures. Finding
suitable study groups for this purpose can therefore be
difficult. Our multivariate analyses were adjusted for the
asbestos exposure, previous smoking and other potential
confounders to ensure that these do not explain our findings.
In these multivariate analyses, ex-smoking was related to
emphysema only and asbestos exposure was related to
irregular/linear opacities only, which suggests that any
major residual confounding by these factors is unlikely.
Our scoring of the lung parenchymal signs was mostly
based on published guidelines and reference images. There
might be over- or underdetection of the abnormalities as in
any such study. However, if such misclassification is notrelated to the exposure status (in this case the SHS
exposure), it is random and leads to an underestimation of
any true effects rather than to any systematic bias. The
interpreters had several years of experience in assessing
HRCT scans, using the window settings, of which they had
had experience in clinical practice. To control for any
potential bias due to the two separate image reader teams,
we adjusted for this effect in the models.Conclusions
Our study of asbestos-exposed workers showed that SHS
exposure can induce processes in the lungs detected as GGO
and linear/irregular opacities in HRCT. Such findings may be
the early signs of RB or DIP. Thus our study supports previous
evidence that SHS has adverse effects on the lungs that can
be detected by objective radiological methods. Such effects
of SHS exposure on HRCT should be investigated in larger
samples with heavier exposure levels before making any
definite conclusions, but identifying suitable study groups
for this purpose may be challenging.Conflict of Interest
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